As a recognized leader in the contract research organization (CRO) industry for conducting complex Phase 3 trials, PharPoint Research has contributed expert services critical to the approval of many important drugs. PharPoint Research has participated in 137 Phase 3 studies in many therapeutic areas and indications, including cardiovascular, central nervous system (pain and neurology), infectious disease, and oncology. Our significant Phase 3 experience encompasses 50 indications. We have provided biostatistics and data management services for dozens of these Phase 3 trials. PharPoint is a full service CRO that provides support for clinical trials at every level and phase. Our network of best in class expertise allows us to provide an accomplished service for Phase 3 studies of all types.
About the Author
Expanded Consulting Services
We recently expanded our consulting services in response to a growing need from clients. Read the full release here.